S&P 500 Futures
(0.05%) 5 209.25 points
Dow Jones Futures
(0.20%) 39 076 points
Nasdaq Futures
(-0.13%) 18 171 points
Oil
(-0.25%) $78.28
Gas
(-0.50%) $2.18
Gold
(-0.37%) $2 322.50
Silver
(-0.53%) $27.47
Platinum
(-0.24%) $962.55
USD/EUR
(0.10%) $0.929
USD/NOK
(0.41%) $10.87
USD/GBP
(0.21%) $0.798
USD/RUB
(-0.21%) $91.15

Aktualne aktualizacje dla Coloplast A/S [CLPBY]

Giełda: OTC Sektor: Healthcare Branża: Medical Instruments & Supplies
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 0.00%

Ostatnio aktualizowano6 geg. 2024 @ 22:59

1.53% $ 12.60

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 22:59):

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally...

Stats
Dzisiejszy wolumen 66 620.00
Średni wolumen 111 213
Kapitalizacja rynkowa 27.84B
EPS $0.598 ( 2023-06-30 )
Następna data zysków ( $0.0800 ) 2024-05-09
Last Dividend $0.0740 ( 2023-05-19 )
Next Dividend $0 ( N/A )
P/E 39.38
ATR14 $0.0240 (0.19%)

Wolumen Korelacja

Długi: 0.12 (neutral)
Krótki: -0.17 (neutral)
Signal:(47.347) Neutral

Coloplast A/S Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Coloplast A/S Korelacja - Waluta/Towar

The country flag -0.58
( weak negative )
The country flag -0.75
( moderate negative )
The country flag 0.00
( neutral )
The country flag -0.56
( weak negative )
The country flag 0.64
( weak )
The country flag 0.69
( moderate )

Coloplast A/S Finanse

Annual 2023
Przychody: $24.50B
Zysk brutto: $16.33B (66.64 %)
EPS: $22.21
FY 2023
Przychody: $24.50B
Zysk brutto: $16.33B (66.64 %)
EPS: $22.21
FY 2022
Przychody: $22.58B
Zysk brutto: $15.53B (68.78 %)
EPS: $22.15
FY 2021
Przychody: $19.43B
Zysk brutto: $13.31B (68.53 %)
EPS: $2.27

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0.210
(N/A)
$0
(N/A)
$0.0740
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Coloplast A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.57 - average (85.65%) | Divividend Growth Potential Score: 5.74 - Stable (14.78%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0810 2021-05-14
Last Dividend $0.0740 2023-05-19
Next Dividend $0 N/A
Payout Date 2023-05-30
Next Payout Date N/A
# dividends 5 --
Total Paid Out $0.649 --
Avg. Dividend % Per Year 0.00% --
Score 2.9 --
Div. Sustainability Score 6.57
Div.Growth Potential Score 5.74
Div. Directional Score 6.15 --
Next Divdend (Est)
(2024-10-01)
$0.00796 Estimate 3.61 %
Dividend Stability
0.29 Very Poor
Dividend Score
2.90
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
UNCHF Ex Dividend Knight 2023-12-28 Semi-Annually 0 0.00%
JPNRF Ex Dividend Junior 2023-09-28 Sporadic 0 0.00%
BKGFY Ex Dividend Knight 2023-08-18 Semi-Annually 0 0.00%
RSMDF Ex Dividend Knight 2023-08-16 Quarterly 0 0.00%
EXPGY Ex Dividend Knight 2023-06-22 Semi-Annually 0 0.00%
YAHOF Ex Dividend Junior 2024-03-28 Annually 0 0.00%
LOGN Ex Dividend Knight 2023-09-14 Quarterly 0 0.00%
CFRUY Ex Dividend Knight 2023-09-21 Annually 0 0.00%
SNPHF Ex Dividend Knight 2023-09-28 Annually 0 0.00%
GBOOY Ex Dividend Junior 2023-06-15 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1951.5006.119.16[0 - 0.5]
returnOnAssetsTTM0.1001.2006.667.99[0 - 0.3]
returnOnEquityTTM0.4241.5006.409.60[0.1 - 1]
payoutRatioTTM0.957-1.0000.433-0.433[0 - 1]
currentRatioTTM0.5320.800-2.34-1.871[1 - 3]
quickRatioTTM0.3240.800-2.80-2.24[0.8 - 2.5]
cashRatioTTM0.04841.500-0.842-1.263[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM9.311.0007.667.66[3 - 30]
operatingCashFlowPerShareTTM25.302.001.5683.14[0 - 30]
freeCashFlowPerShareTTM19.612.000.1950.389[0 - 20]
debtEquityRatioTTM1.430-1.5004.28-6.42[0 - 2.5]
grossProfitMarginTTM0.6671.0002.212.21[0.2 - 0.8]
operatingProfitMarginTTM0.2731.0006.536.53[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2561.0009.699.69[0.2 - 2]
assetTurnoverTTM0.5150.8009.907.92[0.5 - 2]
Total Score6.57

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM3.921.0009.710[1 - 100]
returnOnEquityTTM0.4242.507.699.60[0.1 - 1.5]
freeCashFlowPerShareTTM19.612.003.460.389[0 - 30]
dividendYielPercentageTTM0.05091.5008.730[0 - 0.4]
operatingCashFlowPerShareTTM25.302.001.5683.14[0 - 30]
payoutRatioTTM0.9571.5000.433-0.433[0 - 1]
pegRatioTTM2.091.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2211.0006.970[0.1 - 0.5]
Total Score5.74

Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej